Evidence map›Paper›PMID 39924163›Full record

ArticleJournal of fish diseases2025

Development of a Tetrahymena thermophila-Based Vaccine Expressing Miamiensis avidus Ciliary Proteins to Combat Scuticociliatosis.

Yuho Watanabe, Maho Kotake, Hiromi Matsuoka, Tomoyoshi Yoshinaga, Shin-Ichi Kitamura

Abstract read
In one paragraph

Article in Journal of fish diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuho WatanabeDepartment of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5878-3656
Maho KotakeDepartment of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Hiromi MatsuokaDepartment of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Tomoyoshi YoshinagaDepartment of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Shin-Ichi KitamuraGraduate School of Bioresources, Mie University, Tsu, Mie, Japan.

Funding

Japan Society for the Promotion of Science
6 · The paper itself

Abstract

Miamiensis avidus is a parasitic pathogen responsible for scuticociliatosis, a lethal infection affecting marine fish worldwide, including Japanese flounder. Immunisation with formalin-killed M. avidus has shown promise in inducing protective immunity, positioning it as a potential vaccine candidate against scuticociliatosis. However, challenges such as the high cost of producing sufficient cells and inconsistent quality due to the lack of cryopreservation methods hinder its development. In this study, we expressed M. avidus ciliary proteins in Tetrahymena, a culturable ciliate, and used these cells to immunise Japanese flounder. The immunised fish produced antibodies against M. avidus. Additionally, immunisation with two transgenic Tetrahymena strains, each expressing different ciliary proteins, induced the production of antibodies against two serotypes of the parasite. In challenge experiments, fish immunised with the transgenic Tetrahymena showed prolonged survival compared to the control group, highlighting the potential of this approach as a vaccine candidate. These findings suggest that transgenic Tetrahymena cells could be a viable platform for developing vaccines against multiple serotypes of M. avidus.

Indexed as

Ciliophora InfectionsFish DiseasesFlounderProtozoan ProteinsProtozoan VaccinesTetrahymena thermophilaAnimalsProtozoan ProteinsProtozoan Vaccinesciliary proteinMiamiensis avidusscuticociliatosisTetrahymena thermophilavaccine

Identifiers

PMID39924163
PMCPMC12068840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.